for the Period Ended 29 February 2024
Balance sheet | |
Additional notes | |
Balance sheet notes |
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Called up share capital not paid: |
|
|
|
Fixed assets | |||
Investments: | 3 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Debtors: | 4 |
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: | 5 |
(
|
(
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: | 6 |
(
|
(
|
Total net assets (liabilities): |
( |
( |
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Profit and loss account: |
( |
( |
|
Total Shareholders' funds: |
( |
( |
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 29 February 2024
Basis of measurement and preparation
for the Period Ended 29 February 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 29 February 2024
Property Investment £800,003.00 The company holds 100% freehold property known as 79 High Street, Harlesden, London, NWIO 4NS. Catto Limited £550,000.00 The company holds I 00% of Catto Limited's share capital with CRN 01448519 trading as Catto Pharmacy located at 79 High Street, Harlesden, London, NW10 4NS
for the Period Ended 29 February 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Other debtors |
|
|
Total |
|
|
Debtors due after more than one year: |
|
|
for the Period Ended 29 February 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Trade creditors |
|
|
Accruals and deferred income |
|
|
Total |
|
|
for the Period Ended 29 February 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Other creditors |
|
|
Total |
|
|